NYSE · CIK 0000721371 · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Cardinal Health, Inc.
CAH chart by TradingView
PRICE HISTORY
LIVE · NYSECAH chart by TradingView
- REVENUE FY2025 ENDED JUN 2025
- $223B
- EBITDA
- $3.1B
- FREE CASH FLOW
- $1.9B
- EPS
- $6.45
- GROSS MARGIN
- 3.67%
- ROIC
- —
Q2 FY26ENDED DEC 2025HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
29.3x
+50%10.3x7198.4x
⤢
P / SALES (TTM)
0.2x
-14%0.1x0.2x
⤢
P / BOOK
—
+259%2.2x15.5x
⤢
EV / EBITDA (TTM)
—
⤢
EV / REVENUE (TTM)
—
⤢
FCF YIELD (TTM)
11.30%
+1.1pp-1.68%23.60%
⤢
DIVIDEND YIELD (TTM)
—
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$65.6B
+114%⤢
EBITDA (DERIVED)
$0.9B
+26%⤢
NET INCOME
$0.5B
+21%⤢
EPS (DILUTED)
$1.97
+69%⤢
REVENUE GROWTH YOY
18.75%
-2.1pp-4.34%22.44%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
0.85%
-1.8pp-3.32%6.12%
⤢
RETURN ON CAPITAL
—
⤢
RETURN ON EQUITY (TTM)
—
+34.9pp-461.33%81.48%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN3.65%
OPERATING MARGIN1.08%
NET MARGIN0.71%
FCF MARGIN0.85%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.6B
-31%⤢
STOCK-BASED COMP
$0.1B
+235%⤢
CAPITAL EXPENDITURE
$0.1B
+20%⤢
SHARES OUTSTANDING
0.24B
-28%⤢
DIVIDEND / SHARE
$0.51
+32%BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$2.8B
+7%⤢
TOTAL DEBT
—
⤢
DEBT / EBITDA (TTM)
—
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 89.57%INSIDERS 0.43%OTHER / RETAIL 10.00%1,955 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 12.17% | 28.5M | $6.74B | -0.5% |
| Vanguard Capital Management LLC | 6.53% | 15.3M | $3.61B | NEW |
| Vanguard Portfolio Management LLC | 5.86% | 13.7M | $3.25B | NEW |
| State Street Corporation | 5.16% | 12.1M | $2.85B | -3.5% |
| Geode Capital Management, LLC | 2.81% | 6.6M | $1.56B | +0.8% |
| Morgan Stanley | 2.12% | 5.0M | $1.17B | -3.3% |
| Wellington Management Group, LLP | 1.83% | 4.3M | $1.01B | -17.2% |
| FMR, LLC | 1.81% | 4.2M | $1.00B | -7.8% |
| WCM Investment Management, LLC | 1.71% | 4.0M | $947.2M | -0.6% |
| Invesco Ltd. | 1.50% | 3.5M | $830.3M | +35.9% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.